Foghorn Therapeutics Q2 FY26 net loss narrows to $7.2 million; collaboration revenue rises to $16.1 million

Reuters2026/08/06 11:23

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Foghorn Therapeutics posted a Q2 net loss of $7.2 million, narrowing from a $17.9 million loss a year earlier.
Collaboration revenue rose to $16.1 million from $7.6 million, driven by a $14.2 million cumulative catch-up adjustment tied to updated future costs.
R&D expenses fell to $18.5 million from $21.8 million, while G&A costs eased to $6.4 million from $6.9 million.
Cash, cash equivalents, and marketable securities totaled $167.6 million as of June 30, with runway into the first half of 2028.
The Phase 1 dose-escalation trial for FHD-909 (LY4050784) is advancing with NSCLC as the primary target; selective EP300 degraders remain on track for a 2027 IND.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Foghorn Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-053817), on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Foghorn Therapeutics Q2 FY26 net loss narrows to $7.2 million; collaboration revenue rises to $16.1 million

You may also like

Crypto prices